Evaluation and management of BK virus-associated nephropathy following allogeneic hematopoietic cell transplantation

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 11, 2011, Pages 1589-1593

  Raval, Mihir ^a   Gulbis, Alison ^b   Bollard, Catherine ^c   Leen, Ann ^c   Chemaly, Roy ^b   Shpall, Elizabeth ^b   Lahoti, Amit ^b   Kebriaei, Partow ^b  

^a UNIVERSITY OF NORTH DAKOTA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Antiviral therapy; BK virus nephropathy; Hematopoietic cell transplantation

Indexed keywords

CIDOFOVIR; IMMUNOGLOBULIN; LEFLUNOMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BK VIRUS; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY INFECTION; ORGAN TRANSPLANTATION; POSTOPERATIVE INFECTION; REVIEW; VIRUS INFECTION; VIRUS PATHOGENESIS;

ANTIVIRAL AGENTS; BK VIRUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; NEPHRITIS, INTERSTITIAL; TRANSPLANTATION, HOMOLOGOUS;

EID: 80054855618     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.07.010     Document Type: Review

References (38)

1. Knowles W.A., Pipkin P., Andrews N., et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003, 71:115-123.
2. Hirsch H.H. BK virus: opportunity makes a pathogen. Clin Infect Dis 2005, 41:354-360.
3. Randhawa P., Uhrmacher J., Pasculle W., et al. A comparative study of BK and JC virus infections in organ transplant recipients. J Med Virol 2005, 77:238-243.
4. Hirsch H.H., Knowles W., Dickenmann M., et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002, 347:488-496.
5. Nickeleit V., Klimkait T., Binet I.F., et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000, 342:1309-1315.
6. Ahsan N., Shah K.V. Polyomaviruses and human diseases. Adv Exp Med Biol 2006, 577:1-18.
7. Bohl D.L., Brennan D.C. BK virus nephropathy and kidney transplantation. Clin J Am Soc Nephrol 2007, 2(Suppl 1):S36-S46.
8. Arthur R.R., Shah K.V., Baust S.J., Santos G.W., Saral R. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med 1986, 315:230-234.
9. Arthur R.R., Shah K.V., Charache P., Saral R. BK and JC virus infections in recipients of bone marrow transplants. J Infect Dis 1988, 158:563-569.
10. Apperley J.F., Rice S.J., Bishop J.A., et al. Late-onset hemorrhagic cystitis associated with urinary excretion of polyomaviruses after bone marrow transplantation. Transplantation 1987, 43:108-112.
11. Lekakis L.J., Macrinici V., Baraboutis I.G., Mitchell B., Howard D.S. BK virus nephropathy after allogeneic stem cell transplantation: a case report and literature review. Am J Hematol 2009, 84:243-246.
12. Iwamoto S., Azuma E., Hori H., et al. BK virus-associated fatal renal failure following late-onset hemorrhagic cystitis in an unrelated bone marrow transplantation. Pediatr Hematol Oncol 2002, 19:255-261.
13. Shapiro S., Robin M., Esperou H., et al. Polyomavirus nephropathy in the native kidneys of an unrelated cord blood transplant recipient followed by a disseminated polyomavirus infection. Transplantation 2006, 82:292-293.
14. Limaye A.P., Smith K.D., Cook L., et al. Polyomavirus nephropathy in native kidneys of non-renal transplant recipients. Am J Transplant 2005, 5:614-620.
15. Hirsch H.H., Steiger J. Polyomavirus BK. Lancet Infect Dis 2003, 3:611-623.
16. Azzi A., Cesaro S., Laszlo D., et al. Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients. J Clin Virol 1999, 14:79-86.
17. Silva Lde P., Patah P.A., Saliba R.M., et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type. Haematologica 2010, 95:1183-1190.
18. Chakrabarti S., Osman H., Collingham K., et al. Polyoma viruria following T-cell-depleted allogeneic transplants using Campath-1H: incidence and outcome in relation to graft manipulation, donor type and conditioning. Bone Marrow Transplant 2003, 31:379-386.
19. Leung A.Y., Yuen K.Y., Kwong Y.L. Polyoma BK virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: a changing paradigm. Bone Marrow Transplant 2005, 36:929-937.
20. Childs R., Sanchez C., Engler H., et al. High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine. Bone Marrow Transplant 1998, 22:889-893.
21. Hirsch H.H. Polyomavirus BK nephropathy: a (re-)emerging complication in renal transplantation. Am J Transplant 2002, 2:25-30.
22. Haines H.L., Laskin B.L., Goebel J., et al. Blood, and not urine, BK viral load predicts renal outcome in children with hemorrhagic cystitis following hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011.
23. Binggeli S., Egli A., Schaub S., et al. Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients. Am J Transplant 2007, 7:1131-1139.
24. Egli A., Kohli S., Dickenmann M., Hirsch H.H. Inhibition of polyomavirus BK-specific T-Cell responses by immunosuppressive drugs. Transplantation 2009, 88:1161-1168.
25. Brennan D.C., Agha I., Bohl D.L., et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005, 5:582-594.
26. Araya C.E., Lew J.F., Fennell R.S., Neiberger R.E., Dharnidharka V.R. Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy. Pediatr Transplant 2006, 10:32-37.
27. Bjorang O., Tveitan H., Midtvedt K., Broch L.U., Scott H., Andresen P.A. Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient. Nephrol Dial Transplant 2002, 17:2023-2025.
28. Faguer S., Hirsch H.H., Kamar N., et al. Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation. Transpl Int 2007, 20:962-969.
29. Josephson M.A., Gillen D., Javaid B., et al. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation 2006, 81:704-710.
30. Johnston O., Jaswal D., Gill J.S., Doucette S., Fergusson D.A., Knoll G.A. Treatment of polyomavirus infection in kidney transplant recipients: a systematic review. Transplantation 2010, 89:1057-1070.
31. Topalis D., Lebeau I., Krecmerova M., Andrei G., Snoeck R. Activity of different classes of acyclic nucleoside phosphonates against BK virus in primary human renal cells. Antimicrob Agents Chemother 2011, 55:1961-1967.
32. Waldman W.J., Knight D.A., Blinder L., et al. Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology 1999, 42:412-418.
33. Williams J.W., Javaid B., Kadambi P.V., et al. Leflunomide for polyomavirus type BK nephropathy. N Engl J Med 2005, 352:1157-1158.
34. Bernhoff E., Tylden G.D., Kjerpeseth L.J., Gutteberg T.J., Hirsch H.H., Rinaldo C.H. Leflunomide inhibition of BK virus replication in renal tubular epithelial cells. J Virol 2010, 84:2150-2156.
35. Hilton R., Tong C.Y. Antiviral therapy for polyomavirus-associated nephropathy after renal transplantation. J Antimicrob Chemother 2008, 62:855-859.
36. Leung A.Y., Chan M.T., Yuen K.Y., et al. Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2005, 40:528-537.
37. Dropulic L.K., Jones R.J. Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant 2008, 41:11-18.
38. Gerdemann U., Christin A.S., Vera J.F., et al. Nucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host. Mol Ther 2009, 17:1616-1625.